Ohio State Early Investor Network Disclaimer

OSEIN does not provide investment advice, and the information contained in this memo should not be solely relied upon for making investment decisions. Investors are encouraged to conduct their own due diligence and seek professional advice before making any investment. OSEIN does not assume any liability or responsibility for investment outcomes. Additionally, AI was used to review, synthesize, and prepare the following information.

Investing in early-stage and angel investments is inherently risky, and investors should be aware that they may lose their entire investment. By proceeding with any investment, investors acknowledge and assume these risks and understand that the outcomes can be unpredictable and may not result in financial gain.

Company: smallTalk

Website: https://www.smalltalk.tech/

LinkedIn: linkedin.com/company/smalltalk-tech

Venture360 Page: https://ohiostateearlyinvestornetwork.venture360.co/companies/138794-smalltalk-technology-inc

Pitch Deck

Financials

Market Research

Data Room

Description

smallTalk Healthcare Technology Systems (formerly Thrive Neuromedical) is a Columbus, Ohio-based neurodevelopmental medical device company developing technology to improve brain development and long-term language outcomes for premature infants in the neonatal intensive care unit (NICU). The company combines evidence-based caregiver voice therapy with proprietary hardware and software to address one of the largest unmet needs in neonatal care: improving neurodevelopmental outcomes after preterm birth. Its commercialization strategy begins with the NICU Egg speaker platform before expanding to the FDA-regulated Active Egg neurodevelopmental therapy system.

Investor Questions + Answers

Opportunity Review

Strengths: